StockMarketWire.com - Veterinary medicines supplier Animalcare has received marketing authorisation for Project Quattro - a product from its development pipeline - from the Veterinary Medicines Directorate.

Marketing authorisation is a prerequisite for placing a new veterinary medicinal product on the market, after routine approvals for product packaging, allowing Animalcare to make final preparations for a full commercial launch.

For commercial reasons the full details of Project Quattro will be given at launch, with first sales expected to take place by the end of the current financial year (30 June).

Chief executive Stephen Wildridge said: "The continued growth of our licensed veterinary medicines portfolio is an important aspect of our growth strategy.

"As we announced at our recent Interim Results, the trading in our core business is driven by new product introductions through the year and the news that the development of Project Quattro is advancing as planned is further testament to the delivery of our strategy."




Story provided by StockMarketWire.com